Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-24

Clinical Trial Update: Cutivate Lotion HPA Axis Pediatric Study [Phase 4]

View source ↗

Summary

Phase 4 pediatric HPA axis study of Cutivate Lotion (fluocinonide) for atopic dermatitis has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cutivate Lotion (fluocinonide)

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-24